<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
Information to be included in statements filed pursuant to 13d-1(a)
and amendments thereto filed pursuant to 13d-2(a)
Under the Securities Exchange Act of 1934
(Amendment No. __________)
WORLD OF SCIENCE, INC.
----------------------
(Name of Issuer)
Common Stock, $.01 par value
----------------------------
(Title of Class of Securities)
981500101
---------
(CUSIP Number)
Catherine A. King, Esq.
Harris Beach & Wilcox, LLP
130 East Main Street
Rochester, New York 14604
(716) 232-4440
(Name, Address and Telephone Number of Person Authorized to Receive Notes and
Communications)
October 1, 1999
---------------
(Date of Event which requires filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g),
check the following box[_].
Page 1 of 4
<PAGE>
- ----------------------- ---------------------
CUSIP NO. 981500101 PAGE 2 OF 4 PAGES
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Fred H. Klaucke
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (a) [_]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
SOURCE OF FUNDS
4
PF
- ------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) [_]
5
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
United States
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF 1,542,000
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
227,140* *Shares owned jointly with spouse
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING 1,542,000
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
227,140* *Shares owned jointly with spouse
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
1,769,140
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
12
[_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
37.4%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON
14
IN
- ------------------------------------------------------------------------------
<PAGE>
Item 1. Title and Class of Securities.
This Schedule relates to the Common Stock, par value $.01 per share, of World of
Science, Inc. (the "Issuer"). The address of the Issuer's principal executive
offices is:
900 Jefferson Road, Building Four
Rochester, New York 14623
Item 2. Identity and Background
This Schedule is being filed by Fred H. Klaucke, the President and Chief
Executive Officer of World of Science, Inc.
Fred H. Klaucke has not been, during the last five years, (a) convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors) or
(b) a party to a civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding was or is subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state securities laws or finding
any violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration
This Schedule is being filed in connection with Mr. Klaucke's purchase of
302,000 shares of Common Stock of the Issuer. The total consideration paid for
the shares was $264,250, and was paid by Mr. Klaucke with his personal funds.
Item 4. Purpose of Transaction.
Personal investment.
Item 5. Interest in Securities of Issuer.
(a) 1,769,140 shares of Common Stock, which constitutes approximately
37.4% of the Issuer's total number of outstanding shares of
Common Stock.
(b) Mr. Klaucke has sole power to vote and dispose of 1,542,000
shares of Common Stock of the Issuer. He has shared power, with
his spouse, to vote and dispose of 227,140 shares of Common Stock
of the Issuer which he and his spouse own jointly.
(c) On September 30, 1999, Mr. Klaucke acquired 20,000 shares of
Common Stock of the Issuer in an open market transaction. The
purchase price was $1.00 per share.
(d) As set forth in Item 5.(b), Mr. Klaucke owns 227,140 shares of
Common Stock of the Issuer jointly with his spouse - Laura J.
Klaucke - (4.8%).
(e) Not applicable.
Item 6. Contracts, Arrangements, Undertakings or Relationships with respect to
Securities of the Issuer.
No contracts, arrangements, understandings or relationships exist among the
person named in Item 2 above, or any other person with respect to any securities
of the Issuer, including by not limited to, transfer or voting of such
securities, finders' fees, joint ventures, loan or option arrangements, puts or
calls, guarantees of profits, division of profits or loss, or the giving or
withholding of proxies.
Item 7. Material to be Filed as Exhibits.
Not applicable.
Page 3 of 4
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated October 7, 1999
/s/ Fred H. Klaucke
---------------------------------------
(Signature)
Fred H. Klaucke
---------------------------------------
(Name)
Page 4 of 4
